Fondation ARCAD   Report issue

Foundation Phase 2 Phase 3
Founded: Levallois-Perret France (2006)

Organization Overview

First Clinical Trial
2020
NCT04268121
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fondation ARCAD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 7